Companies /Healthcare
Danaher Corp
NYSE: DHR Diagnostics & Research
$219.14
▲ $1.68 (+0.77%) today
Markets open · 10:55am ET

Danaher (DHR) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
80%
EPS beat rate
+6.92%
Avg. EPS surprise
Consecutive EPS beats
DHR vs Market · 30-day return after each reportDHRS&P 500
−14%−7%0%+7%+12.4%+1.5%Q2 25+6.7%−1.3%Q3 25−10.7%−1.4%Q4 25−12.5%+4.6%Q1 26+5.2%+3.6%Q2 26
−14%−7%0%+7%Q2 25Q3 25Q4 25Q1 26Q2 26
DHR EPS Trend · estimate vs actualEstimateActual
$0.00$0.70$1.40$2.10$1.64$1.80Q2 25$1.72$1.89Q3 25$2.19$2.23Q4 25$1.94$2.06Q1 26
$0.00$0.70$1.40$2.10Q2 25Q3 25Q4 25Q1 26
DHR Revenue Trend · estimate vs actualEstimateActual
$0$2.0B$4.0B$6.0B$5.8B$5.9BQ2 25$6.0B$6.1BQ3 25$6.8B$6.8BQ4 25$6.0B$6.0BQ1 26
$0$2.0B$4.0B$6.0BQ2 25Q3 25Q4 25Q1 26

How Often Does Danaher Beat Earnings Estimates?

Danaher beat EPS estimates in 4 of its last 5 reported quarters, and has beaten 4 quarters in a row.

DHR quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $1.94 — $6.3B —
Q1 2026 $2.06 est. $1.94 +6.38% $6.0B est. $6.0B −0.77%
Q4 2025 $2.23 est. $2.19 +1.79% $6.8B est. $6.8B +0.42%
Q3 2025 $1.89 est. $1.72 +9.78% $6.1B est. $6.0B +0.92%
Q2 2025 $1.80 est. $1.64 +9.74% $5.9B est. $5.8B +1.79%

Figures from SEC filings and company reports. Not investment advice.